Switching From Mochi Health to PlexusDx: What to Expect in 2026

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

The primary commercial difference is pricing structure: Mochi Health uses per-dose pricing where your medication cost increases as your clinician raises your dose, while PlexusDx charges the same flat rate regardless of dose. Mochi's advertised starting-dose cost is $60/month for semaglutide medication plus a $39 first-month introductory membership rate (total $99 first month), but the standard ongoing membership fee is not documented in available evidence—and the medication cost rises with each titration step. PlexusDx charges $189/month for semaglutide injection on a month-to-month basis ($169/month on 3-month commitment, $149/month on 6-month commitment), and that rate stays constant whether you're at 0.25 mg or 2.4 mg. The actual cost difference depends on your eventual maintenance dose and Mochi's ongoing membership fee, both of which should be confirmed at Mochi's checkout before comparing total cost over 12 months.

At-a-glance comparison

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Starting-dose pricing vs maintenance-dose pricing

Mochi Health advertises a starting-dose all-in cost of $99/month for compounded semaglutide ($60 medication + $39 first-month membership) and $129/month for compounded tirzepatide ($90 medication + $39 first-month membership), according to the company's per-dose pricing page and medication pages captured September 4, 2026. Two critical limitations apply to these figures:

1. The $39 membership is explicitly labeled as a first-month introductory rate. Mochi's FAQ states "first month membership" and includes the caveat "confirm ongoing membership after promo." The standard ongoing membership fee is not documented in available evidence and must be confirmed at Mochi's checkout.
2. Mochi's per-dose pricing model means medication cost increases as your clinician raises your dose. The $60 semaglutide and $90 tirzepatide figures apply only to starting doses. The per-dose schedule for maintenance doses (e.g., semaglutide 1.0 mg or 2.4 mg, tirzepatide 7.5 mg or 15 mg) is not published in the captured sources.

This structure makes advertised entry costs lower for some patients but renders a complete 12-month cost comparison impossible without the ongoing membership rate and the full dose-pricing schedule. If you are currently on a maintenance dose at Mochi, your actual monthly medication cost is higher than the $60 or $90 starting figures—confirm your current per-dose rate and the standard membership fee before calculating total annual cost.

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection on a month-to-month basis, with no membership fee and no dose-related price increase. A patient at 0.25 mg semaglutide pays $189; the same patient at 2.4 mg pays $189. The rate drops to $169/month semaglutide ($269/month tirzepatide) on a 3-month commitment and $149/month semaglutide ($249/month tirzepatide) on a 6-month commitment. Multi-month commitments bill monthly at the lower rate.

Effective 12-month cost (our calculation):

• PlexusDx semaglutide month-to-month: $189 × 12 = $2,268 ($189/month effective)
• PlexusDx semaglutide 3-month commitment: $169 × 12 = $2,028 ($169/month effective)
• PlexusDx semaglutide 6-month commitment: $149 × 12 = $1,788 ($149/month effective)
• PlexusDx tirzepatide month-to-month: $289 × 12 = $3,468 ($289/month effective)
• PlexusDx tirzepatide 3-month commitment: $269 × 12 = $3,228 ($269/month effective)
• PlexusDx tirzepatide 6-month commitment: $249 × 12 = $2,988 ($249/month effective)

A comparable 12-month calculation for Mochi requires the standard membership fee and per-dose pricing at your target maintenance dose, neither of which is available in the evidence captured September 4, 2026. Verify both figures at joinmochi.com before comparing annual cost.

What changes when you switch

Prescription and clinician review

A new provider at PlexusDx will review your intake, weight-loss history, current dose, and any side effects or contraindications before writing a new prescription. You cannot transfer an active Mochi prescription to PlexusDx; the PlexusDx clinician writes a new order through the intake process. Bring records of your current dose, titration timeline, and any adverse reactions to streamline the review. If you are stable on a maintenance dose, the PlexusDx provider may continue that dose or adjust based on your response and clinical guidelines.

Timing and overlap

To avoid a gap in medication, complete the PlexusDx intake and receive provider approval before your final Mochi shipment runs out. PlexusDx shipments typically arrive within 5–7 business days of provider approval, but allow extra days for intake review and any follow-up questions from the provider. If you prefer a short overlap to ensure continuity, time your first PlexusDx order to arrive before your Mochi supply is fully depleted. Cancel your Mochi subscription after your first PlexusDx shipment is confirmed in transit to avoid double billing.

Dose continuation and titration pace

If you are already at a maintenance dose (e.g., semaglutide 1.7 mg or 2.4 mg, tirzepatide 10 mg or 15 mg), the PlexusDx provider will evaluate whether that dose remains appropriate and may continue it if your tolerance and results are stable. If you are mid-titration, the provider will determine the next step based on your response, not solely on a predetermined schedule. Dose adjustments at PlexusDx follow clinical judgment and patient tolerance; the flat-rate pricing means a dose increase does not trigger a price increase.

Billing and commitment options

PlexusDx offers month-to-month billing with no membership fee, plus optional 3-month and 6-month commitment plans at lower per-month rates. All plans bill monthly (the commitment plans bill monthly at the reduced rate for the commitment period). Mochi bills monthly with separate medication and membership charges; the membership fee recurs each month, and the medication charge reflects your current dose under the per-dose model. Switching to PlexusDx eliminates the separate membership line item and the dose-related price variability.

Customer support and review record

Mochi Health holds a 4.5-star rating on Trustpilot with approximately 18,000 reviews (captured September 4, 2026). One captured Trustpilot report described a provider appearing late and not engaging during a consultation—an individual account that may not represent typical experience but reflects a reported service concern. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Both platforms offer asynchronous messaging with clinical teams; response-time expectations and care-team accessibility should be confirmed during intake.

Choose Mochi Health if…

• You are at a low starting dose and expect to remain there for an extended period. Mochi's per-dose model may offer lower medication cost at the lowest doses, though the ongoing membership fee (not documented in available evidence) must be added to the medication cost for a complete monthly total.
• You prefer a higher aggregate Trustpilot rating and review volume. Mochi's 4.5-star rating across ~18,000 reviews reflects broader customer feedback than PlexusDx's 4.3-star rating, though individual service reports vary on both platforms.
• You want access to branded GLP-1 options alongside compounded. Mochi offers branded semaglutide and tirzepatide pathways in addition to compounded; pricing for branded options was not captured in available evidence.

Where PlexusDx fits

PlexusDx is designed for patients who prioritize cost predictability across the full titration curve and want to eliminate separate membership fees. The flat-rate pricing model means your monthly cost is known in advance regardless of your eventual maintenance dose—useful for budgeting over 12+ months and particularly advantageous once you reach higher doses where per-dose pricing would increase. The absence of a membership fee simplifies billing to a single monthly charge. Patients already stable on maintenance doses or those expecting to titrate to higher doses may find the dose-invariant structure more economical than a per-dose model, though a complete cost comparison requires Mochi's standard membership rate and maintenance-dose medication pricing (both not documented in available evidence as of September 4, 2026).

PlexusDx works with licensed 503A compounding pharmacies and includes provider access, medication, and shipping in the monthly rate. The 3-month and 6-month commitment plans ($169/month and $149/month for semaglutide, $269/month and $249/month for tirzepatide) offer lower per-month rates for patients confident in a longer engagement. A licensed provider reviews every intake to determine whether a prescription is appropriate.

Methodology and freshness

Mochi Health pricing, membership structure, and per-dose model verified from joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide, captured September 4, 2026 at 13:49:55 UTC. The $39 membership figure is explicitly labeled "first month membership" with the caveat "confirm ongoing membership after promo"; the standard ongoing membership rate is not documented in the captured sources. Medication costs ($60 semaglutide, $90 tirzepatide) apply to starting doses only; per-dose pricing for maintenance doses is not published in available evidence.

PlexusDx pricing verified from plexusdx.com product pages, captured September 6, 2026 at 11:10:40 UTC. Trustpilot ratings for both providers captured September 4, 2026. The 12-month cost calculations labeled "our calculation" are arithmetic projections (monthly rate × 12 months) and assume consistent dosing; they do not account for dose changes, pauses, or refund scenarios. Readers should confirm current pricing, membership fees, dose-progression costs, and cancellation terms at each provider's checkout before committing.

Frequently Asked Questions

Can I transfer my Mochi prescription directly to PlexusDx?

No. You cannot transfer an active prescription between telehealth GLP-1 providers. A licensed PlexusDx provider will review your intake and medical history and write a new prescription if you are deemed appropriate. Bring records of your current dose and titration timeline to streamline the review process.

Will I pay more or less per month after switching from Mochi to PlexusDx?

It depends on your current dose and Mochi's standard ongoing membership fee (not documented in available evidence). At starting doses with Mochi's first-month promotional membership, Mochi's advertised cost is lower. At higher maintenance doses, PlexusDx's flat rate may become more economical because Mochi's per-dose medication cost increases with each titration step. Confirm your current per-dose rate and standard membership fee at Mochi, then compare against PlexusDx's $189/month semaglutide or $289/month tirzepatide (month-to-month) or lower commitment rates.

How long does the switch take from intake to first shipment?

PlexusDx intake typically takes about 60 seconds to complete. A licensed provider reviews your submission, usually within 24–48 hours. If approved, your first shipment ships within 1–2 business days and arrives within 5–7 business days of provider approval. Total elapsed time from intake to delivery is generally 7–10 days, though timing varies by provider review load and shipping destination.

Does PlexusDx charge the same rate at every dose level?

Yes. PlexusDx charges $189/month for compounded semaglutide injection (month-to-month) and $289/month for compounded tirzepatide injection (month-to-month), regardless of dose. A patient at 0.25 mg semaglutide pays the same monthly rate as a patient at 2.4 mg. The 3-month and 6-month commitment plans offer lower per-month rates ($169 and $149 for semaglutide, $269 and $249 for tirzepatide) with the same dose-invariant structure.

What if I'm mid-titration when I switch—will PlexusDx continue my current schedule?

The PlexusDx provider will review your titration history, current dose, tolerance, and results, then determine the next step based on clinical judgment. If you are tolerating your current dose well and progressing toward your goal, the provider may continue a similar titration pace. If you have experienced side effects or your response has plateaued, the provider may adjust timing or dose increments. Dose decisions follow clinical guidelines and individual patient response, not a rigid predetermined schedule.

Sources

• Mochi Health per-dose pricing model and starting-dose medication costs: joinmochi.com/blog/per-dose-pricing-mochi-health (accessed September 4, 2026)
• Mochi Health compounded tirzepatide pricing and membership structure: joinmochi.com/medications/compounded-tirzepatide (accessed September 4, 2026)
• PlexusDx semaglutide and tirzepatide injection pricing, dose policy, and commitment plans: plexusdx.com/products/semaglutide-injection and plexusdx.com/products/tirzepatide-injection (accessed September 6, 2026)
• Mochi Health Trustpilot rating: trustpilot.com (accessed September 4, 2026)
• PlexusDx Trustpilot rating: verified 4.3-star rating, 79% five-star, 83% four-star or higher (verified September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.